AMRZ vs PSKY Stock Comparison
Compare AMRZ and PSKY across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between AMRZ and PSKY?
PSKY leads the current stock comparison as Paramount Skydance Corporation Class B Common Stock, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Amrize Ltd vs Paramount Skydance Corporation Class B Common Stock
PSKY leads
PSKY leads by 14 AIQ points, primarily on Momentum and Value, but the lead has narrowed from 22 points over 30 sessions.
Stable: 5 of 6 evidence groups support PSKY, and its lead is narrowing.
Amrize Ltd
Paramount Skydance Corporation Class B Common Stock
The Algovestiq AIQ Score currently favors PSKY over AMRZ, 46 versus 32 as of Sep 11, 2026. PSKY's advantage is driven primarily by stronger momentum and value. PSKY also shows the stronger technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor PSKY today, and the comparison is rated Stable on stability: the leader's advantage has been narrowing. PSKY lead: Weakening — the AIQ differential moved from 22 to 14 points over 30 sessions.
Compare Amrize Ltd and Paramount Skydance Corporation Class B Common Stock across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare AMRZ and PSKY against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum24 vs 56PSKY +32
- Value41 vs 64PSKY +23
- Risk Resilience26 vs 40PSKY +14
5 of 6 evidence groups favor PSKY. PSKY’s edge is concentrated in momentum and value.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -1
No new signals fired.
Largest factor move: Momentum +7
No new signals fired.
PSKY's lead widened by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — AMRZ and PSKY both carry a full feed there.
The central trade-off
PSKY (Paramount Skydance Corporation Class B Common Stock): the stronger current systematic profile, led by momentum and value.
AMRZ (Amrize Ltd): the counter-case, on fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PSKYPSKY on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AMRZAMRZ on combined revenue and EPS growth.
Value
PSKYPSKY on the peer-relative Value factor, by 23 points.
Momentum
PSKYPSKY on the Momentum factor, by 32 points.
Lower downside
PSKYPSKY on Risk Resilience, by 14 points.
Analyst upside
PSKYPSKY on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AMRZ | PSKY | Note |
|---|---|---|---|
| Implied upside to target | +41.1% | +69.8% | PSKY has more room |
| Target dispersion | +52.5% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 9 | 1 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor PSKY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PSKY | 32 vs 46 |
| Fundamentals | AMRZ | revenue growth 60.4% vs -5.9%; EPS growth 5.1% vs -73.3% |
| Valuation | PSKY | Value 41 vs 64 |
| Technicals | PSKY | Price vs 50-day -15% vs 10.4%; vs 200-day -23.3% vs -5% |
| Risk Resilience | PSKY | Risk Resilience 26 vs 40 |
| Analyst expectations | PSKY | Target upside 41.1% vs 69.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMRZ and PSKY and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PSKY.
How the comparison changed
119 daily snapshots · May 4 – Sep 10PSKY lead: Weakening — the AIQ differential moved from 22 to 14 points over 30 sessions.
- Today
- PSKY +14
- 32 vs 46
- 7 sessions ago
- PSKY +14
- 36 vs 50
- 30 sessions ago
- PSKY +22
- 30 vs 52
- 90 sessions ago
- PSKY +12
- 30 vs 42
The lead changed hands 6 times in this window, most recently on Aug 6 when PSKY moved ahead of AMRZ.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 5 bearish / 1 neutral, conflicted
- Death Cross Active — bearish, trend, long horizon (12.14%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- BB Lower Band Breach — bullish, volatility, short horizon
0 bullish / 2 bearish / 2 neutral
- Death Cross Active — bearish, trend, long horizon (13.80%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.12%)
AMRZ is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.2%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +2.12%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AMRZ closes the Momentum gap — currently 32 points behind, the largest single contributor to PSKY's edge.
- 2AMRZ's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3PSKY starts generating bearish momentum or trend signals.
- 4The narrowing continues — the lead has already given back 8 points over 30 sessions, and a further 14-point move would eliminate PSKY's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AMRZ leads on balance| Metric | AMRZ | PSKY |
|---|---|---|
| Revenue growth (YoY) | 60.4% | -5.9% |
| EPS growth (YoY) | 5.1% | -73.3% |
| Gross margin | — | 28.8% |
| Operating margin | — | -18.4% |
| Return on equity (TTM) | — | -5.3% |
| Debt to equity | — | 1.29 |
Performance
PSKY leads 4 of 6 windows| Metric | AMRZ | PSKY |
|---|---|---|
| 1 week (5 sessions) | -5.9% | -5.4% |
| 1 month (20 sessions) | -12.8% | 9.3% |
| 3 months (63 sessions) | -19.9% | 0.7% |
| 6 months (126 sessions) | -30.5% | 4.4% |
| Year to date | -20.8% | -22.5% |
| 1 year (252 sessions) | -25% | -31.7% |
Technicals
PSKY has the stronger structure| Metric | AMRZ | PSKY |
|---|---|---|
| RSI (14) | 30 | 51.8 |
| ADX (14) | 29.6 | 34.4 |
| Price vs 50-day | -15% | 10.4% |
| Price vs 200-day | -23.3% | -5% |
| Volatility (1M, annualized) | 28.3% | 38.3% |
Risk
PSKY is the more resilient| Metric | AMRZ | PSKY |
|---|---|---|
| Beta | 1.35 | 0.75 |
| Sharpe ratio | -0.71 | -0.53 |
| Sortino ratio | -1.21 | -0.98 |
| Max drawdown | -38.6% | -60.4% |
| Current drawdown | -38.6% | -47.4% |
| Annualized volatility | 37.4% | 53.4% |
| Value at risk (95%) | -3.3% | -4.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMRZ or PSKY?
On the Algovestiq AIQ Score, PSKY is the stronger of the two as of Sep 11, 2026, scoring 46 against AMRZ's 32. The edge comes from momentum and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMRZ or PSKY the better buy right now?
PSKY carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor PSKY over AMRZ?
The composite weights Quality, Value, Momentum and Risk Resilience. PSKY leads Momentum by 32 points; PSKY leads Value by 23 points; PSKY leads Risk Resilience by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMRZ or PSKY?
Analyst price targets imply +41.1% upside for AMRZ and +69.8% for PSKY, so the Street currently favors PSKY. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMRZ or PSKY?
PSKY is the better-valued of the two on the peer-relative Value factor. PSKY on the peer-relative Value factor, by 23 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMRZ or PSKY?
AMRZ on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMRZ or PSKY?
PSKY on the Momentum factor, by 32 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMRZ or PSKY?
PSKY is the more resilient of the two, so the other name carries the higher downside risk. PSKY on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMRZ more profitable than PSKY?
Margin data is not comparable for both names in the current snapshot.
Is PSKY's lead over AMRZ getting stronger or weaker?
PSKY lead: Weakening — the AIQ differential moved from 22 to 14 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 6 times in that window, most recently on 2026-08-06, when PSKY moved ahead of AMRZ.
What would change the AMRZ vs PSKY verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AMRZ closes the Momentum gap — currently 32 points behind, the largest single contributor to PSKY's edge; AMRZ's Death Cross Active resolves — a bearish trend rule currently active against it; PSKY starts generating bearish momentum or trend signals; the narrowing continues — the lead has already given back 8 points over 30 sessions, and a further 14-point move would eliminate PSKY's advantage entirely.
What do the current signals say about AMRZ and PSKY?
AMRZ: 2 bullish / 5 bearish / 1 neutral, conflicted. PSKY: 0 bullish / 2 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMRZ is Death Cross Active (bearish, long horizon). On PSKY it is Death Cross Active (bearish, long horizon).
Compare AMRZ and PSKY with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.